Almirall SA

Almirall SA is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. Founded in 1943, the company has established itself as a leader in dermatology, with a strong focus on developing treatments for skin diseases and conditions.

With a commitment to improving patients’ lives, Almirall invests significantly in research and development, aiming to bring new therapies to market that address unmet medical needs. The company’s portfolio includes a range of prescription medications, as well as over-the-counter products, catering to various therapeutic areas.

Almirall operates in multiple countries, with a strong presence in Europe and North America. The company collaborates with healthcare professionals, researchers, and other stakeholders to ensure that its products meet the highest standards of safety and efficacy.

In addition to its focus on dermatology, Almirall is also exploring opportunities in other therapeutic areas, including respiratory diseases and autoimmune disorders. The company’s vision is to be a trusted partner in healthcare, providing innovative solutions that enhance patient outcomes.

Almirall is committed to sustainability and corporate social responsibility, actively engaging in initiatives that promote health and well-being in the communities it serves. The company believes in fostering a culture of innovation, collaboration, and integrity among its employees.

Key Highlights:

• Founded: 1943
• Core Focus: Dermatology and biopharmaceuticals
• Global Presence: Operations in Europe and North America
• Commitment: Research and development of innovative therapies
• Sustainability: Active engagement in corporate social responsibility initiatives